Metallothionein-mediated neuroprotection in genetically engineered mouse models of Parkinson's disease

Molecular Brain Research

Volumn 134, Issue 1, 2005, Pages 67-75

  Ebadi, Manuchair ^a   Brown Borg, Holly ^a   El Refaey, Hesham ^a   Singh, Brij B ^a   Garrett, Scott ^b   Shavali, Shaik ^b   Sharma, Sushil K ^b  

^a UNIVERSITY OF NORTH DAKOTA   (United States)

^b UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

18F DOPA; a synuclein knockout mice; Ames dwarf mice; Fetal stem cell transplantation; Homozygous weaver mutant mice (WMhomo); Metallothionein double gene knockout mice; Metallothionein transgenic mice; MicroPET imaging; Parkinson's disease

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ADENOSINE TRIPHOSPHATE; ALPHA SYNUCLEIN; CASPASE 3; DNA FRAGMENT; DOPA; GLUTAMATE DECARBOXYLASE; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LINSIDOMINE; MEMBRANE PROTEIN; METALLOTHIONEIN; PEROXYNITRITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); ROTENONE; SALSOLINOL; TRANSIENT RECEPTOR POTENTIAL CHANNEL; TRANSIENT RECEPTOR POTENTIAL CHANNEL 1 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TYROSINE 3 MONOOXYGENASE; UBIDECARENONE; UNCLASSIFIED DRUG;

AGING; APOPTOSIS; CELL AGGREGATION; CELL INCLUSION; CEREBELLUM; CORPUS STRIATUM; GENETIC ENGINEERING; GENOTYPE; HIPPOCAMPUS; HUMAN; KNOCKOUT MOUSE; LIFESPAN; NERVE DEGENERATION; NEUROPATHOLOGY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; ONCOGENE C FOS; ONCOGENE C JUN; PARKINSON DISEASE; PARKINSONISM; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTO ONCOGENE; REVIEW; TRANSGENIC MOUSE; WILD TYPE;

EID: 15744373545     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molbrainres.2004.09.011     Document Type: Review

References (48)

1. A. Aguzzi, S. Brandner, S. Marino, and J. Steinbach Transgenic and knockout mice in the study of neurodegenerative diseases J. Mol. Med. 74 1996 111 126
2. R. Betarbet, B.T. Sherer, and T.J. Greenamyre Animal models of Parkinson's disease BioEssays 24 2002 308 318
3. A. Björklund, and O. Lindvall Catecholaminergic Brain Stem Regulatory Systems 1986 Waverly Press
4. H.M. Brown-Borg, K.E. Borg, C.J. Meliska, and A. Bartke Dwarf mice and the ageing process Nature 384 1996 33
5. L. Bruijn, and D. Cleveland Mechanisms of selective motor neuron death in ALS: insights from transgenic mouse models of motor neuron disease Neuropathol. Appl. Neurobiol. 22 1996 373 387
6. R. Crowther Steps towards a mouse model of Alzheimer's disease BioEssays 17 1995 593 595
7. W. Daurer, and S. Przedborski Parkinson's disease: mechanisms and models Neuron 39 2003 88 909
8. A. Douhou, T. Debier, M.G. Murer, L. Do, N. Dufour, V. Blanchard, S. Moussaoui, G.A Bohme, Y. Agid, and R. Raisman-Vozari Effect of chronic treatment with riluzole on the NS DA-ergic system in wv/wv mice Exp. Neurol. 176 2002 247 253
9. M. Ebadi, and S. Sharma Complex-1 is inhibited and NFκβ is induced in weaver mutant mice J. Cell. Mol. Med. 8 2004 213 222
10. M. Ebadi, and S. Sharma Peroxynitrite and mitochondrial dysfunction in the pathogenesis of Parkinson's disease Antioxid. Redox Signal. 5 2003 319 335
11. M. Ebadi, S. Sharma, D. Muralikrishnan, S. Shavali, J. Eken, P. Sangchot, B. Chetsawang, and L. Brekke Metallothionein provide ubiquinone-mediated neuroprotection in Parkinson's disease Proc. West. Pharmacol. 45 2002 36 38
12. M. Ebadi, S.K. Sharma, A. Ajimaporn, and S. Maanum Weaver mutant mouse in progression of neurodegeneration in Parkinson's disease M. Ebadi R.F. Pfeiffer Parkinson's Disease 2005 CRC Press Florida 541 559
13. M. Ebadi, S. Sharma, P. Ghafourifar, H. Brown-Barg, and H. El Rafaey Peroxynitrite in the pathogenesis of Parkinson's disease and the neuroprotective role of metallothioneins Methods Enzymol. 2005 (in press)
14. H. El Refaey, M. Ebadi, C.A. Kuszynski, J. Sweeney, F.M. Hamada, and A. Hamed Identification of metallothionein receptors in astrocytes Neurosci. Lett. 231 1997 131 134
15. S.H. Garrett, M. Belcastro, M.A. Sens, S. Somji, and D.A. Sens Acute exposure of arsenite induces metallothionein isoform-specific gene expression in human proximal tubule cells J. Toxicol. Environ. Health, A 26 64 (4) 2001 343 355
16. M. Gupta, D.L. Petten, and B. Ghetti Selective loss of monoaminergic neurons in weaver mutant mice-an immunocytochemical study Brain Res. 402 1987 379 382
17. Y. Kitamura, S. Shimohama, A. Akaike, and T. Taniguchi The parkinsonian models: invertebrates to mammals Jpn. J. Pharmacol. 84 2000 237 243
18. M. Lee, D. Borchelt, P. Wong, S. Sisodia, and D. Price Transgenic models of neurodegenerative diseases Curr. Opin. Neurobiol. 6 1996 651 660
19. A. Ludolph Animal models for motor neuron diseases: research directions Neurology 47 1996 S228 S232
20. P. Maharajan, V. Maharajan, G. Ravagnan, and G. Paino The weaver mutant mouse: a model to study the ontogeny of dopamine transmission systems and their role in drug addiction Prog. Neurobiol. 64 2001 269 276
21. L.B. Menalled, and M.F Chesselet Mouse models of Huntington's disease Trends Pharmacol. Sci. 23 2002 32 39
22. 3H]glutamate binding sites and AMPA receptor subunit RNA transcripts in the striatum of normal and wv/wv mice and affects of ventral mesencephalic grafts Cell Transplant 8 1999 11 23
23. N. Patil, D.R. Cox, D. Bhat, M. Faham, R.M. Myers, and A.S. Peterson A potassium channel mutation in weaver mice implicates membrane excitability in granule cell differentiation Nat. Genet. 11 1995 126 129
24. S. Prusiner Prion diseases and the BSE crisis Science 278 1997 245 251
25. P. Rakic, and L. Sidman Sequence of developmental abnormalities leading to granule cell deficit in cerebellar cortex of weaver mutant mice J. Comp. Neurol. 152 1973 103 132
26. D.C. Rubinstein Lessons from animal models of Huntington's disease Trends Genet. 18 2002 202 209
27. M.J. Schmidt, B.D. Sawyer, K.W. Perry, M.M. Foreman, and B. Ghetti Dopamine deficiency in the weaver mutant mouse J. Neurosci. 2 1982 376 380
28. S. Sharma, and M. Ebadi Metallothionein attenuates 3- morpholinosydnonimine (SIN-1)-induced oxidative stress in DA-ergic neurons Antioxid. Redox Signal. 5 2003 251 264
29. S. Sharma, and M. Ebadi An improved method for analyzing coenzyme Q homologues and multiple detection of rare biological samples J. Neurosci. Methods 137 2004 1 8
30. +)-induced apoptosis in SK-N-SH neurons J. Neurocytol. 32 2003 329 343
31. 10 in Parkinson's disease Methods Enzymol. 382 2004 488 509
32. 18F-DOPA in weaver mutant mice J. Neurochem. 2004 (submitted)
33. M. Ebadi, S. Sharma, S. Wanpen, S. Shavali, Metallothionein isoforms attenuate peroxunitrite-induced oxidative stress in Parkinson's disease, in: M. Ebadi, R.F. Pfeiffer (Eds.), Parkinson's Disease, CRC Press, Florida, pp. 483-503.
34. S. Shavali, E.C. Carlson, J.C. Swinscoe, and M. Ebadi 1-Benzyl-1, 2,3,6-tetrahydroisoquinoline, a Parkinsonism-inducing endogenous toxin increases alpha-synuclein expression and causes nuclear damage in human dopaminergic cells J. Neurosci. Res. 76 2004 563 571
35. R.L. Sidman, M.C. Green, and S.H. Appel Catalog of the Neurological Mutants of the Mouse 1965 Harvard University Press Cambridge, MA 66 67
36. + influx by interaction with a site in the C terminus of TrpC1 Mol. Cell 9 2002 739 750
37. R.J. Smeyne, and D. Goldowitz Development and death of external granular layer cells in the weaver mouse cerebellum: a quantitative study J. Neurosci. 9 1989 1608 1620
38. M.W. Smith III, T.R. Cooper, T.H. Joh, and D.E. Smith Cell loss and class distribution of TH-I cells in the substantia nigra of the neurological mutant, weaver Brain Res. 510 1990 242 250
39. F.O. Tinmarlar, B.J. Richard, M.W.S. Harrison, C. Henchcliffe, C.A. Mason, S.K. Roffler-Tarlov, and R.E. Burke Neuron death in substantia nigra of weaver mouse occurs late in development and is not apoptotic J. Neurosci. 16 1996 6134 6145
40. L.C. Triarhou Biology and pathology of weaver mutant mouse Adv. Exp. Med. Biol. 517 2002 15 42
41. L.C. Triarhou, J. Norton, and B. Ghetti Mesencephalic dopamine cell deficit involves areas A8, A9 and A10 in weaver mutant mice Exp. Brain Res. 70 1988 256 265
42. S. Wanpen, P. Govitrapong, S. Shavali, P. Sangchot, and M. Ebadi Salsolinol, a dopamine-derived tetrahydroisoquinoline, induces cell death by causing oxidative stress in dopaminergic SH-SY-5Y cells, and the said effect is attenuated by metallothionein Brain Res. 1005 2004 67 76
43. S.G. Xu, C. Prasad, and D.E. Smith Neurons exhibiting DA D2 receptor immunoreactivity in the substantia nigra of the mutant weaver mouse Neuroscience 89 1999 191 207
44. + or salsolinol neurotoxicity in human SH-SY5Y neuroblastems cells J. Biol. Chem. 2004 (submitted)
45. H.M. Brown-Borg Hormonal regulation of aging and life span Trends Endocrinol. Metab. 14 2003 151 153
46. H.M. Brown-Borg, W.T. Johnson, S.G. Rakoczy, and M.A. Romanick Mitochondrial oxidantproduction and oxidative damage in Ames dwarf mice J. Am. Aging Assoc. 24 2001 85 96
47. H.M. Brown-Borg, and S.G. Rakoczy Catalase expression in delayed and premature aging mouse models Exp. Gerontol. 35 2000 199 212
48. A. Bartke, H.M. Brown-Borg, B. Kinney, J. Mattison, C. Wright, S. Hauck, K. Coschigano, and J. Kopchick Growth hormone and aging J. Am. Aging Assoc. 23 2000 219 225